Cargando…
The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control
BACKGROUND: Trachoma, the worldwide leading infectious cause of blindness, is due to repeated conjunctival infection with Chlamydia trachomatis. The effects of control interventions on population levels of infection and active disease can be promptly measured, but the effects on severe ocular sequel...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691478/ https://www.ncbi.nlm.nih.gov/pubmed/19529762 http://dx.doi.org/10.1371/journal.pntd.0000462 |
_version_ | 1782167874181267456 |
---|---|
author | Gambhir, Manoj Basáñez, Maria-Gloria Burton, Matthew J. Solomon, Anthony W. Bailey, Robin L. Holland, Martin J. Blake, Isobel M. Donnelly, Christl A. Jabr, Ibrahim Mabey, David C. Grassly, Nicholas C. |
author_facet | Gambhir, Manoj Basáñez, Maria-Gloria Burton, Matthew J. Solomon, Anthony W. Bailey, Robin L. Holland, Martin J. Blake, Isobel M. Donnelly, Christl A. Jabr, Ibrahim Mabey, David C. Grassly, Nicholas C. |
author_sort | Gambhir, Manoj |
collection | PubMed |
description | BACKGROUND: Trachoma, the worldwide leading infectious cause of blindness, is due to repeated conjunctival infection with Chlamydia trachomatis. The effects of control interventions on population levels of infection and active disease can be promptly measured, but the effects on severe ocular sequelae require long-term monitoring. We present an age-structured mathematical model of trachoma transmission and disease to predict the impact of interventions on the prevalence of blinding trachoma. METHODOLOGY/PRINCIPAL FINDINGS: The model is based on the concept of multiple reinfections leading to progressive conjunctival scarring, trichiasis, corneal opacity and blindness. It also includes aspects of trachoma natural history, such as an increasing rate of recovery from infection and a decreasing chlamydial load with subsequent infections that depend upon a (presumed) acquired immunity that clears infection with age more rapidly. Parameters were estimated using maximum likelihood by fitting the model to pre-control infection prevalence data from hypo-, meso- and hyperendemic communities from The Gambia and Tanzania. The model reproduces key features of trachoma epidemiology: 1) the age-profile of infection prevalence, which increases to a peak at very young ages and declines at older ages; 2) a shift in this prevalence peak, toward younger ages in higher force of infection environments; 3) a raised overall profile of infection prevalence with higher force of infection; and 4) a rising profile, with age, of the prevalence of the ensuing severe sequelae (trachomatous scarring, trichiasis), as well as estimates of the number of infections that need to occur before these sequelae appear. CONCLUSIONS/SIGNIFICANCE: We present a framework that is sufficiently comprehensive to examine the outcomes of the A (antibiotic) component of the SAFE strategy on disease. The suitability of the model for representing population-level patterns of infection and disease sequelae is discussed in view of the individual processes leading to these patterns. |
format | Text |
id | pubmed-2691478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-26914782009-06-15 The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control Gambhir, Manoj Basáñez, Maria-Gloria Burton, Matthew J. Solomon, Anthony W. Bailey, Robin L. Holland, Martin J. Blake, Isobel M. Donnelly, Christl A. Jabr, Ibrahim Mabey, David C. Grassly, Nicholas C. PLoS Negl Trop Dis Research Article BACKGROUND: Trachoma, the worldwide leading infectious cause of blindness, is due to repeated conjunctival infection with Chlamydia trachomatis. The effects of control interventions on population levels of infection and active disease can be promptly measured, but the effects on severe ocular sequelae require long-term monitoring. We present an age-structured mathematical model of trachoma transmission and disease to predict the impact of interventions on the prevalence of blinding trachoma. METHODOLOGY/PRINCIPAL FINDINGS: The model is based on the concept of multiple reinfections leading to progressive conjunctival scarring, trichiasis, corneal opacity and blindness. It also includes aspects of trachoma natural history, such as an increasing rate of recovery from infection and a decreasing chlamydial load with subsequent infections that depend upon a (presumed) acquired immunity that clears infection with age more rapidly. Parameters were estimated using maximum likelihood by fitting the model to pre-control infection prevalence data from hypo-, meso- and hyperendemic communities from The Gambia and Tanzania. The model reproduces key features of trachoma epidemiology: 1) the age-profile of infection prevalence, which increases to a peak at very young ages and declines at older ages; 2) a shift in this prevalence peak, toward younger ages in higher force of infection environments; 3) a raised overall profile of infection prevalence with higher force of infection; and 4) a rising profile, with age, of the prevalence of the ensuing severe sequelae (trachomatous scarring, trichiasis), as well as estimates of the number of infections that need to occur before these sequelae appear. CONCLUSIONS/SIGNIFICANCE: We present a framework that is sufficiently comprehensive to examine the outcomes of the A (antibiotic) component of the SAFE strategy on disease. The suitability of the model for representing population-level patterns of infection and disease sequelae is discussed in view of the individual processes leading to these patterns. Public Library of Science 2009-06-16 /pmc/articles/PMC2691478/ /pubmed/19529762 http://dx.doi.org/10.1371/journal.pntd.0000462 Text en Gambhir et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Gambhir, Manoj Basáñez, Maria-Gloria Burton, Matthew J. Solomon, Anthony W. Bailey, Robin L. Holland, Martin J. Blake, Isobel M. Donnelly, Christl A. Jabr, Ibrahim Mabey, David C. Grassly, Nicholas C. The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control |
title | The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control |
title_full | The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control |
title_fullStr | The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control |
title_full_unstemmed | The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control |
title_short | The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control |
title_sort | development of an age-structured model for trachoma transmission dynamics, pathogenesis and control |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691478/ https://www.ncbi.nlm.nih.gov/pubmed/19529762 http://dx.doi.org/10.1371/journal.pntd.0000462 |
work_keys_str_mv | AT gambhirmanoj thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT basanezmariagloria thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT burtonmatthewj thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT solomonanthonyw thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT baileyrobinl thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT hollandmartinj thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT blakeisobelm thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT donnellychristla thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT jabribrahim thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT mabeydavidc thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT grasslynicholasc thedevelopmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT gambhirmanoj developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT basanezmariagloria developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT burtonmatthewj developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT solomonanthonyw developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT baileyrobinl developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT hollandmartinj developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT blakeisobelm developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT donnellychristla developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT jabribrahim developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT mabeydavidc developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol AT grasslynicholasc developmentofanagestructuredmodelfortrachomatransmissiondynamicspathogenesisandcontrol |